Cited by 1,410Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityAdipose Tissue and Metabolism

The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

Hajer, G. R., van Haeften, T. W., Visseren, F. L.J.·2008·European Heart Journal

DOI 10.1093/eurheartj/ehn387

Open this paper in CoChat — free account

Abstract

The classical perception of adipose tissue as a storage place of fatty acids has been replaced over the last years by the notion that adipose tissue has a central role in lipid and glucose metabolism and produces a large number of hormones and cytokines, e.g. tumour necrosis factor-alpha, interleukin-6, adiponectin, leptin, and plasminogen activator inhibitor-1. The increased prevalence of excessive visceral obesity and obesity-related cardiovascular risk factors is closely associated with the rising incidence of cardiovascular diseases and type 2 diabetes mellitus. This clustering of vascular risk factors in (visceral) obesity is often referred to as metabolic syndrome. The close relationship between an increased quantity of visceral fat, metabolic disturbances, including low-grade inflammation, and cardiovascular diseases and the unique anatomical relation to the hepatic portal circulation has led to an intense endeavour to unravel the specific endocrine functions of this visceral fat depot. The objective of this paper is to describe adipose tissue dysfunction, delineate the relation between adipose tissue dysfunction and obesity and to describe how adipose tissue dysfunction is involved in the development of diabetes mellitus type 2 and atherosclerotic vascular diseases. First, normal physiology of adipocytes and adipose tissue will be described.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehn387

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901
Adiponectin and Adiponectin Receptors
Kadowaki, T., & Yamauchi, T. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0005 · Cited by 2,634
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y., Ruiz‐Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,983
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,782
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of pima indians
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Visceral fat adipokine secretion is associated with systemic inflammation in obese humans
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007) · Diabetes · doi:10.2337/db06-1656 · Cited by 1,417 · cited 1×
“study in extremely obese patients indicates that visceral fat is the main contributor of plasma IL-6 concentration.(31) It is therefore conceivable that viscerally produced adipocytokines directly influ-”
Background
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17797 · Cited by 1,312
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction
Boden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4
Lee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011695200 · Cited by 1,299
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
Relationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288
Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation
Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., et al. (2007) · Diabetes · doi:10.2337/db06-0911 · Cited by 1,257 · cited 1×
“They elicit the inhibition of adiponectin gene transcription illustrated by decreased adiponectin promoter and PPAR- g activity, by reduced adiponectin mRNA (messenger ribonucleic acid) stability and finally by a decline in adiponectin expression as shown in obese mice.(53,55) Simultaneous induction of leptin and PAI-…”
Background
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213
Abdominal Adiposity and Coronary Heart Disease in Women
Rexrode, K. M. (1998) · JAMA · doi:10.1001/jama.280.21.1843 · Cited by 1,208
Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S.
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2745 · Cited by 1,199
Reduction of Macrophage Infiltration and Chemoattractant Gene Expression Changes in White Adipose Tissue of Morbidly Obese Subjects After Surgery-Induced Weight Loss
Cancello, R., Henegar, C., Viguerie, N., Taleb, S., Poitou, C., Rouault, C., Coupaye, M., Pelloux, V., Hugol, D., Bouillot, J.-L., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2277 · Cited by 1,164
AMP-activated protein kinase signaling in metabolic regulation
Long, Y. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29044 · Cited by 1,125
Adiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094
Transient increase in obese gene expression after food intake or insulin administration
Saladin, R., Vos, P. D., Guerre-Millo, M., Leturque, A., Girard, J. R., Staels, B., & Auwerx, J. H. (1995) · Nature · doi:10.1038/377527a0 · Cited by 1,093
A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α
Suganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056 · cited 1×
“Large adipocytes release more (saturated) FFAs which can bind to macrophage toll-like receptor-4 (TLR-4) resulting in NF-kB activation ultimately leading to augmented TNF-a production.(46,47) In turn, macrophage-derived TNF-a activates human adipocytes, thereby further inducing lipolysis and enhancing the expression o…”
Background
ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism.Preprint
Kim, J. B., & Spiegelman, B. M. (1996) · Genes & Development · doi:10.1101/gad.10.9.1096 · Cited by 1,026
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 930
Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress
Pou, K. M., Massaro, J. M., Hoffmann, U., Vasan, R. S., Maurovich‐Horvat, P., Larson, M. G., Keaney, J. F., Meigs, J. B., Lipinska, I., Kathiresan, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.710509 · Cited by 915
Adipose tissue mass can be regulated through the vasculature
Rupnick, M. A., Panigrahy, D., Zhang, C.-Y., Dallabrida, S. M., Lowell, B. B., Langer, R., & Folkman, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162349799 · Cited by 845
Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study
Freeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844
Role of the Toll-like Receptor 4/NF-κB Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages
Suganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., Mizuarai, S., Kotani, H., Yamaoka, S., Miyake, K., Aoe, S., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251608.09329.9a · Cited by 820
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 805
Proopiomelanocortin Neurons Are Direct Targets for Leptin in the Hypothalamus
Cheung, C. C., Clifton, D. K., & Steiner, R. A. (1997) · Endocrinology · doi:10.1210/endo.138.10.5570 · Cited by 769 · cited 1×
“increases hepatic lipid oxidation and lipolysis in skeletal muscle and adipocytes.(19,20) In subjects with decreased fat depots, e.”
Background
Human Leptin Deficiency Caused by a Missense Mutation: Multiple Endocrine Defects, Decreased Sympathetic Tone, and Immune System Dysfunction Indicate New Targets for Leptin Action, Greater Central than Peripheral Resistance to the Effects of Leptin, and Spontaneous Correction of Leptin-Mediated Defects
Ozata, M., Ozdemir, I. C., & Licinio, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5999 · Cited by 739
Activation of the peripheral endocannabinoid system in human obesity
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2838 · Cited by 686
Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin
Kobayashi, H., Ouchi, N., Kihara, S., Walsh, K. X., Kumada, M., Abe, Y., Funahashi, T., & Matsuzawa, Y. (2004) · Circulation Research · doi:10.1161/01.res.0000119921.86460.37 · Cited by 666
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
Vidal‐Puig, A., Jimenez‐Liñan, M., Lowell, B. B., Hamann, A., Hu, E., Spiegelman, B. M., Flier, J. S., & Moller, D. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118703 · Cited by 660
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Weight Loss and the Renin-Angiotensin-Aldosterone System
Engeli, S., Böhnke, J., Gorzelniak, K., Janke, J., Schling, P., Bäder, M., Luft, F. C., & Sharma, A. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000154361.47683.d3 · Cited by 627
Increased Infiltration of Macrophages in Omental Adipose Tissue Is Associated With Marked Hepatic Lesions in Morbid Human Obesity
Cancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J. L., Hugol, D., Coussieu, C., Basdevant, A., Hen, A. B., Bedossa, P., et al. (2006) · Diabetes · doi:10.2337/db06-0133 · Cited by 607
Adipose Development: From Stem Cell to Adipocyte
Otto, T. C., & Lane, M. D. (2005) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230591008189 · Cited by 553
Molecular and anatomical determinants of central leptin resistance
Münzberg, H., & Myers, M. G. (2005) · Nature Neuroscience · doi:10.1038/nn1454 · Cited by 550
Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity
Tsuchida, A., Yamauchi, T., Ito, Y., Hada, Y., Maki, T., Takekawa, S., Kamon, J., Kobayashi, M., Suzuki, R., Hara, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402367200 · Cited by 550
Tumor Necrosis Factor-α Suppresses Adipocyte-Specific Genes and Activates Expression of Preadipocyte Genes in 3T3-L1 Adipocytes
Ruan, H., Hacohen, N., Golub, T. R., Parijs, L. V., & Lodish, H. F. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1319 · Cited by 543
Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity
Blüher, M., Engeli, S., Klöting, N., Berndt, J., Faßhauer, M., Bátkai, S., Pacher, P., Schön, M. R., Jordan, J., & Stümvoll, M. (2006) · Diabetes · doi:10.2337/db06-0812 · Cited by 526
A Review of the Microcirculation of Adipose Tissue: Anatomic, Metabolic, and Angiogenic Perspectives
Crandall, D. L., Hausman, G. J., & Kral, J. G. (1997) · Microcirculation · doi:10.3109/10739689709146786 · Cited by 508
Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation
Massiéra, F., Bloch-Faure, M., Ceiler, D. L., Murakami, K., Fukamizu, A., Gasc, J., Quignard‐Boulangé, A., Négrel, R., Ailhaud, G. P., Seydoux, J., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0457fje · Cited by 505
Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians
Vasseur, F. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2607 · Cited by 495
Adiponectin Multimeric Complexes and the Metabolic Syndrome Trait Cluster
Lara‐Castro, C., Luo, N., Wallace, P., Klein, R. L., & Garvey, W. T. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1105 · Cited by 480
Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension
Furuhashi, M., Ura, N., Higashiura, K., Murakami, H., Tanaka, M., Moniwa, N., Yoshida, D., & Shimamoto, K. (2003) · Hypertension · doi:10.1161/01.hyp.0000078490.59735.6e · Cited by 460
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
Bots, M. L., Visseren, F. L. J., Evans, G. W., Riley, W. A., Revkin, J. H., Tegeler, C. H., Shear, C. L., Duggan, W. T., Vicari, R. M., Grobbee, D. E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61088-5 · Cited by 458
Self-citation
Differential Regulation of Adiponectin Secretion from Cultured Human Omental and Subcutaneous Adipocytes: Effects of Insulin and Rosiglitazone
Motoshima, H., Wu, X., Sinha, M. K., Hardy, V. E., Rosato, E. L., Barbot, D. J., Rosato, F. E., & Goldstein, B. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020635 · Cited by 425
Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults
Duncan, G. E., Perri, M. G., Theriaque, D. W., Hutson, A. D., Eckel, R. H., & Stacpoole, P. W. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.557 · Cited by 425
Adiponectin and Coronary Heart Disease
Sattar, N. A., Wannamethee, S. G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A. M., Danesh, J., & Whincup, P. H. (2006) · Circulation · doi:10.1161/circulationaha.106.618918 · Cited by 415
Fatty Acid Signaling in the β-Cell and Insulin Secretion
Nolan, C. J., Murthy, M. S., Delghingaro‐Augusto, V., Peyot, M., & Prentki, M. (2006) · Diabetes · doi:10.2337/db06-s003 · Cited by 407
Leptin is essential for the hepatic fibrogenic response to chronic liver injury
Leclercq, I. A., Farrell, G. C., Schriemer, R., & Robertson, G. R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00102-2 · Cited by 407
Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight
Baskin, D. G., Lattemann, D. F., Seeley, R. J., Woods, S. C., Porte, D., & Schwartz, M. W. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01974-5 · Cited by 401
Oxygen, a source of life and stress
Brahimi-Horn, M. C., & Pouysségur, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.018 · Cited by 383
Selective parasympathetic innervation of subcutaneous and intra-abdominal fat — functional implications
Kreier, F., Fliers, E., Voshol, P. J., van Eden, C. G., Havekes, L. M., Kalsbeek, A., Heijningen, C. L. V., Sluiter, A. A., Mettenleiter, T. C., Romijn, J. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15736 · Cited by 370
Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet
Flachs, P., Mohamed‐Ali, V., Horakova, O., Rossmeisl, M., Hosseinzadeh‐Attar, M. J., Hensler, M., Ruzickova, J., & Kopecký, J. (2006) · Diabetologia · doi:10.1007/s00125-005-0053-y · Cited by 362
Effects of Pioglitazone on Adipose Tissue Remodeling Within the Setting of Obesity and Insulin Resistance
de Souza, C. J., Eckhardt, M., Gagen, K., Dong, M., Chen, W., Laurent, D., & Burkey, B. F. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1863 · Cited by 351
Nuclear Sterol Regulatory Element-binding Proteins Activate Genes Responsible for the Entire Program of Unsaturated Fatty Acid Biosynthesis in Transgenic Mouse Liver
Shimomura, I., Shimano, H., Korn, B. S., Bashmakov, Y., & Horton, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35299 · Cited by 333
Adiponectin actions in the cardiovascular system
Hopkins, T. A., Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.009 · Cited by 331
Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues
Dusserre, E., Moulin, P., & Vidal, H. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00091-5 · Cited by 326
Dose-Dependent Effects of Recombinant Human Interleukin-6 on Glucose Regulation
Tsigos, C., Papanicolaou, D. A., Kyrou, I., Defensor, R., Mitsiadis, C. S., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4422 · Cited by 324 · cited 1×
“given peripherally results in decreased insulin sensitivity in healthy males.(27) IL-6 upregulates vascular endothelial growth factor”
Background
Role of Selective Leptin Resistance in Diet-Induced Obesity Hypertension
Rahmouni, K., Morgan, D. A., Morgan, G. M., Mark, A. L., & Haynes, W. G. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2012 · Cited by 319
Macrophage-secreted factors induce adipocyte inflammation and insulin resistance
Permana, P. A., Menge, C., & Reaven, P. D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.012 · Cited by 307
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1
Skurk, T., & Hauner, H. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802778 · Cited by 303
PPARγ-Activating Angiotensin Type-1 Receptor Blockers Induce Adiponectin
Clasen, R., Schupp, M., Foryst‐Ludwig, A., Sprang, C., Clemenz, M., Krikov, M., Thöne‐Reineke, C., Unger, T., & Kintscher, U. (2005) · Hypertension · doi:10.1161/01.hyp.0000168046.19884.6a · Cited by 257
Disruption of leptin receptor expression in the pancreas directly affects β cell growth and function in mice
Morioka, T., Asilmaz, E., Hu, J., Dishinger, J. F., Kurpad, A. J., Elias, C. F., Li, H., Elmquist, J. K., Kennedy, R. T., & Kulkarni, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30910 · Cited by 249
Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes
Chen, B., Lam, K. S. L., Wang, Y., Wu, D., Lam, M. C., Shen, J., Wong, L., Hoo, R. L. C., Zhang, J., & Xu, A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.004 · Cited by 238
Plasma leptin and prognosis in patients with established coronary atherosclerosis
Wolk, R. A., Berger, P. B., Lennon, R. J., Brilakis, E. S., Johnson, B. D., & Somers, V. K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.050 · Cited by 235
Co-expression of renin-angiotensin system genes in human adipose tissue
Engeli, S., Gorzelniak, K., Kreutz, R. H., Runkel, N. S. F., Distler, A., & Sharma, A. M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917040-00014 · Cited by 233
High Expression of Complement Components in Omental Adipose Tissue in Obese Men
Gabrielsson, B. G., Johansson, J. M., Lönn, M., Jernås, M., Olbers, T., Peltonen, M., Larsson, I., Lönn, L., Sjöström, L., Carlsson, B., et al. (2003) · Obesity Research · doi:10.1038/oby.2003.100 · Cited by 218
Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level
Winkler, G., Kiss, S., Keszthelyi, L., Sápi, Z., Őry, I., Salamon, F., Kovács, M., Vargha, P., Szekeres, O., Speer, G., et al. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490129 · Cited by 213
Omega-3 fatty acids and cardiovascular disease
von Schacky, C. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3280127af0 · Cited by 207
Plasma Levels of Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex and von Willebrand Factor Are Significant Risk Markers for Recurrent Myocardial Infarction in the Stockholm Heart Epidemiology Program (SHEEP) Study
Wiman, B., Andersson, T., Hallqvist, J., Reuterwall, C., Ahlbom, A., & DeFaire, U. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.2019 · Cited by 203
Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss
Jung, S. H., Park, H. S., Kim, K., Choi, W. H., Ahn, C. W., Kim, B. T., Kim, S. M., Lee, S. Y., Ahn, S. M., Kim, Y. K., et al. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.05.007 · Cited by 199
Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.
Rabinovitch, A., Suarez‐Pinzon, W. L., Strynadka, K., Ju, Q., Edelstein, D., Brownlee, M., Korbutt, G. S., & Rajotte, R. V. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1223 · Cited by 198
Adipokines and Risk of Type 2 Diabetes in Older Men
Wannamethee, S. G., Lowe, G. D. O., Rumley, A., Cherry, L., Whincup, P. H., & Sattar, N. A. (2007) · Diabetes Care · doi:10.2337/dc06-2416 · Cited by 194
Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study
Miller, M., Seidler, A., Moalemi, A., & Pearson, T. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00083-7 · Cited by 193
Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat
Bastelica, D., Morange, P., Berthet, B., Borghi, H., Paulmyer‐Lacroix, O., Grino, M., Juhan-Vague, I., & Alessi, M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101552 · Cited by 190
Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1
Rakatzi, I., Mueller, H., Ritzeler, O., Tennagels, N., & Eckel, J. (2004) · Diabetologia · doi:10.1007/s00125-003-1293-3 · Cited by 183
Cellular mechanisms of insulin resistance in humans
Shulman, G. I. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00350-1 · Cited by 177
Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease
Barter, P. J., & Kastelein, J. J. P. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.042 · Cited by 171
The Association of Differing Measures of Overweight and Obesity With Prevalent Atherosclerosis
See, R., Abdullah, S. M., McGuire, D. K., Khera, A., Patel, M. J., Lindsey, J. B., Grundy, S. M., & de Lemos, J. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.066 · Cited by 168
Hypoadiponectinemia Is Associated With Ischemic Cerebrovascular Disease
Chen, M., Tsai, J. C. ‐., Chung, F., Yang, S.-S., Hsing, L.-L., Shin, S., & Lee, Y. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000157784.25920.a7 · Cited by 168
Adiponectin Receptors in Human Adipose Tissue: Effects of Obesity, Weight Loss, and Fat Depots
Rasmussen, M. S., Lihn, A. S., Pedersen, S. B., Bruun, J. M., Rasmussen, M., & Richelsen, B. (2006) · Obesity · doi:10.1038/oby.2006.5 · Cited by 164
Prevalence of Uncomplicated Obesity in an Italian Obese Population
Iacobellis, G., Ribaudo, M. C., Zappaterreno, A., Iannucci, C. V., & Leonetti, F. (2005) · Obesity Research · doi:10.1038/oby.2005.130 · Cited by 151
Effect of Inhibition of the Renin-Angiotensin System on Development of Type 2 Diabetes Mellitus (Meta-Analysis of Randomized Trials)
Andraws, R., & Brown, D. L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.10.068 · Cited by 149
Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance
Ran, J., Hirano, T., Fukui, T., Saito, K., Kageyama, H., Okada, K., & Adachi, M. (2006) · Metabolism · doi:10.1016/j.metabol.2005.10.009 · Cited by 140
Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men
Chu, N., Spiegelman, D. L., Hotamışlıgil, G. S., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00755-3 · Cited by 138
Elevated Physical Activity and Low Leptin Levels Co-occur in Patients with Anorexia Nervosa
Holtkamp, K., Herpertz‐Dahlmann, B., Mika, C., Heer, M. A., Heussen, N. M., Fichter, M., Herpertz, S., Senf, W., Blum, W. F., Schweiger, U., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030569 · Cited by 131
Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity
Vasseur, F., Helbecque, N., Lobbens, S., Vasseur-Delannoy, V., Dina, C., Clément, K., Boutin, P., Kadowaki, T., Scherer, P. E., & Froguel, P. (2005) · Diabetologia · doi:10.1007/s00125-005-1729-z · Cited by 130
Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study
Strazzullo, P., Barbato, A., Galletti, F., Barba, G., Siani, A., Iacone, R., D’Elia, L., Russo, O., Versiero, M., Farinaro, E., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000239300.48130.07 · Cited by 128
The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years)
Filippi, E., Sentinelli, F., Romeo, S., Arca, M., Berni, A., Tiberti, C., Verrienti, A., Fanelli, M., Fallarino, M., Sorropago, G., et al. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0667-z · Cited by 124
Tumor Necrosis Factor-α and Interferon-γ Inhibit Insulin Secretion and Cause DNA Damage in Unweaned-Rat Islets: Extent of Nitric Oxide Involvement
Dunger, A., Cunningham, J. M., Delaney, C. A., Lowe, J. E., Green, M. H. L., Bone, A. J., & Green, I. C. (1996) · Diabetes · doi:10.2337/diab.45.2.183 · Cited by 115
Intramural Plasminogen Activator Inhibitor Type-1 and Coronary Atherosclerosis
Sobel, B. E., Taatjes, D. J., & Schneider, D. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000091250.53231.4d · Cited by 112
Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes
Zhao, Y.-F., Feng, D. D., & Chen, C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.11.008 · Cited by 110
Gene Expression of Adiponectin Receptors in Human Visceral and Subcutaneous Adipose Tissue Is Related to Insulin Resistance and Metabolic Parameters and Is Altered in Response to Physical Training
Blüher, M., Williams, C. J., Klöting, N., Hsi, A., Ruschke, K., Oberbach, A., Faßhauer, M., Berndt, J., Schön, M. R., Wolk, A., et al. (2007) · Diabetes Care · doi:10.2337/dc07-1257 · Cited by 107
Association between plasma adiponectin levels and unstable coronary syndromes
Wolk, R. A., Berger, P. B., Lennon, R. J., Brilakis, E. S., Davison, D. E., & Somers, V. K. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl361 · Cited by 106
Tumour necrosis factor-α exerts dual effects on human adipose leptin synthesis and release
Zhang, H., Kumar, S., Barnett, A. H., & Eggo, M. C. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00194-x · Cited by 104
Vascular Endothelial Growth Factor Is Induced by the Inflammatory Cytokines Interleukin-6 and Oncostatin M in Human Adipose Tissue In Vitro and in Murine Adipose Tissue In Vivo
Rega‐Kaun, G., Kaun, C., Demyanets, S., Pfaffenberger, S., Rychli, K., Hohensinner, P. J., Kastl, S., Speidl, W. S., Weiss, T. W., Breuss, J. M., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.143081 · Cited by 104
Novel Associations Between Bioavailable Estradiol and Adipokines in Elderly Women With Different Phenotypes of Obesity
Tankó, L. B., Bruun, J. M., Alexandersen, P., Bagger, Y. Z., Richelsen, B., Christiansen, C., & Larsen, P. J. (2004) · Circulation · doi:10.1161/01.cir.0000144470.55149.e5 · Cited by 100
Alterations in lipoprotein lipase in insulin resistance.
Eckel, R. H., Yost, T. J., & Jensen, D. R. (1995) · PubMed · Cited by 94
A central role for hepatocyte growth factor in adipose tissue angiogenesis
Bell, L. N., Cai, L., Johnstone, B. H., Traktuev, D. O., March, K. L., & Considine, R. V. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00272.2007 · Cited by 77
Training and Detraining Effects of a Combined-strength and Aerobic Exercise Program on Blood Lipids in Patients With Coronary Artery Disease
Tokmakidis, S. P., & Volaklis, K. A. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00006 · Cited by 69
Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines
Navasa, M., Gordon, D. A., Hariharan, N., Jamil, H., Shigenaga, J. K., Moser, A. H., Fiers, W., Pollock, A. S., Grünfeld, C., & Feingold, K. R. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32546-3 · Cited by 68
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk—the PIOSTAT Study
Forst, T. M., Pfützner, A., Lübben, G., Weber, M. M., Marx, N., Karagiannis, E., Koehler, C., Baurecht, W., Hohberg, C., & Hanefeld, M. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.007 · Cited by 67
Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study.
Brennan, A. M., Li, T. Y., Kelesidis, I., Gavrila, A., Hu, F. B., & Mantzoros, C. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0635-y · Cited by 54
Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Trials
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
Simvastatin (40 mg/day), Adiponectin Levels, and Insulin Sensitivity in Subjects With the Metabolic Syndrome
Devaraj, S., Siegel, D., & Jialal, I. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.028 · Cited by 49
Relationships Between Indices of Obesity and Its Cardiovascular Comorbidities in a Chinese Population
Li, R., Lu, W., Jia, J., Zhang, S., Shi, L., Li, Y., Yang, Q., & Kan, H. (2008) · Circulation Journal · doi:10.1253/circj.72.973 · Cited by 45
Up-regulation of renal Na+, K+-ATPase: the possible novel mechanism of leptin-induced hypertension.
Bełtowski, J., Jamróz-Wiśniewska, A., Borkowska, E., & Wójcicka, G. (2004) · PubMed · Cited by 45
Short‐term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men
Gouni‐Berthold, I., Berthold, H. K., Chamberland, J. P., Krone, W., & Mantzoros, C. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03080.x · Cited by 41
Plasma Leptin Levels and Coronary Artery Calcification in Older Adults
Iribarren, C., Husson, G., Go, A. S., Lo, J. C.-M., Fair, J. M., Rubin, G. D., Hlatky, M. A., & Fortmann, S. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1138 · Cited by 39
Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease
Hajer, G. R., van der Graaf, Y., Olijhoek, J. K., Edlinger, M., & Visseren, F. L. J. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.013 · Cited by 36
Self-citation
The effects of imidazoline agents on the aggregation of human platelets
Pinthong, D., Songsermsakul, P., Ratanachamnong, P., & Kendall, D. A. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022593 · Cited by 34
The effect of leisure-time physical activity on the presence of metabolic syndrome in patients with manifest arterial disease. The SMART study
Brouwer, B. G., Visseren, F. L. J., & van der Graaf, Y. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.031 · Cited by 30
Self-citation
Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia
Bouhali, T., Brisson, D., St‐Pierre, J., Tremblay, G., Perron, P., Laprise, C., Vohl, M., Vissers, M. N., Hutten, B. A., Després, J., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.035 · Cited by 23
Selective parasympathetic innervation of subcutaneous and intra-abdominal fat — functional implications
Kreier, F., Fliers, E., Voshol, P. J., van Eden, C. G., Havekes, L. M., Kalsbeek, A., Heijningen, C. L. V., Sluiter, A. A., Mettenleiter, T. C., Romijn, J. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215736 · Cited by 21
Lipid‐lowering therapy does not affect the postprandial drop in high density lipoprotein‐cholesterol (HDL‐c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial
Hajer, G. R., Dallinga‐Thie, G. M., der Zee, L. C. V. V., Olijhoek, J. K., & Visseren, F. L. J. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03250.x · Cited by 20
Self-citation
閉塞性肥大型心筋症様の血行動態を呈した「たこつぼ心筋症」の1例
舌間, 夢., 田中, 信., 佐藤真司, 仲吉, 孝., 杉原, 充., 清水知彦, 井上寛子, 池田次郎, 森井, 誠., 麻生, 明., et al. (2008) · Circulation · Cited by 20

Research works printed but not linked: 6

Cheung, 1997, Endocrinology, 138, 4489, 10.1210/en.138.10.4489 · DOI · Paper page
2007, American heart journal, 154, 750
Tsigos, 1997, Journal of Clinical Endocrinology & Metabolism, 82, 4167, 10.1210/jc.82.12.4167 · DOI · Paper page
Ozata, 1999, Journal of Clinical Endocrinology & Metabolism, 84, 3686, 10.1210/jc.84.10.3686 · DOI · Paper page
1995, International journal of obesity, 19, S16
2004, Circulation Research, 94, e27

Sorted by citations

Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies
Manna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,211
The Effect of Mediterranean Diet on Metabolic Syndrome and its Components
Kastorini, C.-M., Milionis, H. J., Esposito, K., Giugliano, D., Goudevenos, J. A., & Panagiotakos, D. B. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.073 · Cited by 1,087
Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Li, S., Shin, H. J., Ding, E. L., & van Dam, R. M. (2009) · JAMA · doi:10.1001/jama.2009.976 · Cited by 991
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
Self-citation
Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance
Du, T., Yuan, G., Zhang, M., Zhou, X., Sun, X., & Yu, X. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0146-3 · Cited by 630

See all 1,410

Authors: Hajer, G. R., van Haeften, T. W., & Visseren, F. L. J.
Affiliations: University Medical Center Utrecht (NL)
Corresponding author: Visseren, F. L.J.
ORCID: Visseren, F. L.J.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2008-09-05
Volume: 29
Issue: 24
Pages: 2959-2971
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/ehn387
OpenAlex: W2100784798
Semantic Scholar: a5a791d646daf7a9ba3a727d27f953ec6ca43ec5
Cited by: 1,410
References: 136
Citations by year: 2026: 23 · 2025: 54 · 2024: 45 · 2023: 55 · 2022: 58 · 2021: 68 · 2020: 83 · 2019: 69 · 2018: 85 · 2017: 88 · 2016: 98 · 2015: 100 · 2014: 134 · 2013: 130 · 2012: 103
FWCI: 7.72
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords: adipose tissue dysfunction, visceral obesity, type 2 diabetes, metabolic syndrome, cardiovascular disease, atherosclerosis, adipokines, adiponectin, leptin, TNF-α, interleukin-6, plasminogen activator inhibitor-1, low-grade inflammation, portal circulation, cardiovascular risk factors
MeSH terms: Adipose Tissue, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Energy Metabolism, Female, Humans, Male, Obesity, Transcription Factors, Adipocytes, Leptin, Metabolic Syndrome, Risk Reduction Behavior, Intra-Abdominal Fat, Atherosclerosis, Subcutaneous Fat, Abdominal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks